tradingkey.logo
tradingkey.logo
Search

Mirum Pharmaceuticals Inc

MIRM
Add to Watchlist
92.540USD
+0.710+0.77%
Market hours 09/21, 13:27ET
5.99BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+0.77%

5 Days

-5.78%

1 Month

-4.67%

6 Months

+4.55%

Year to Date

+17.15%

1 Year

+24.42%

Key Figures

93.180Open
94.570High
19.54KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
91.830Prev. Close
91.470Low
1.82MTurnover
LossP/E Static
-574.98P/B
0.00%Div Yield TTM
-101.04%ROA
130.00052wk High
0.03Volume Ratio
-87.94MNet Profit
64.75MShares
-13.5916EPS TTM
0.50Beta
-335.82%ROE
63.23252wk Low
3.38%Amplitude
82.40%Gross Margin
5.99BMarket Cap
-5.10Reward/Risk
2.92%Risk Rate
More news coming soon, stay tuned...

Mirum Pharmaceuticals Inc's Score

0.06vs previous score
Forecast8.86
Financial Health8.26
Technical3.36
Valuation Dimensions9.70
Institutional Confidence10.00
Risk Assessment6.54

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
139.760Target Price
+41.43%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy66444444
Buy88777666
Hold00000000
Sell00000000
Strong Sell00000000

Mirum Pharmaceuticals Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Strong sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-1.06/-0.68
Revenue / Forecast
176.24M/166.12M

Mirum Pharmaceuticals Inc Profile

SectorPharmaceuticals
Ticker SymbolMIRM
Number of employees322
CountryUnited States of America

Ownership

ShareholdersProportion
Frazier Life Sciences Management, L.P.12.59%
Janus Henderson Investors9.95%
BlackRock Institutional Trust Company, N.A.5.13%
Vanguard Capital Management, LLC3.96%
Shareholder TypesProportion
Investment Advisor/Hedge Fund35.04%
Investment Advisor34.03%
Hedge Fund16.35%
Private Equity13.71%

FAQs

What is the current price of Mirum Pharmaceuticals Inc (MIRM)?

The current price of Mirum Pharmaceuticals Inc (MIRM) is 91.83.

What is the symbol of Mirum Pharmaceuticals Inc?

The ticker symbol of Mirum Pharmaceuticals Inc is MIRM.

What is the 52-week high of Mirum Pharmaceuticals Inc?

The 52-week high of Mirum Pharmaceuticals Inc is 130.00.

What is the 52-week low of Mirum Pharmaceuticals Inc?

The 52-week low of Mirum Pharmaceuticals Inc is 63.23.

What is the market capitalization of Mirum Pharmaceuticals Inc?

The market capitalization of Mirum Pharmaceuticals Inc is 5.95B.

Is Mirum Pharmaceuticals Inc (MIRM) currently rated as Buy, Hold, or Sell?

According to analysts, Mirum Pharmaceuticals Inc (MIRM) has an overall rating of Buy, with a price target of 139.76.

What is the Earnings Per Share (EPS TTM) of Mirum Pharmaceuticals Inc (MIRM)?

The Earnings Per Share (EPS TTM) of Mirum Pharmaceuticals Inc (MIRM) is -13.59.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.